Mobile health to help with breast cancer pill-taking
Part of Cancer, Skin clinical trials.
This study uses text messages to help people with metastatic breast cancer remember to take their daily pills and asks about any missed doses. It aims to improve how well patients stick to their CDK4/6 inhibitor medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have a type of breast cancer called HR-positive, HER2-negative that has spread (metastatic).
- You are starting or have recently started a CDK4/6 inhibitor pill (such as Ibrance, Kisqali, or Verzenio) in a blister pack.
- You have a personal mobile phone that can send and receive text messages.
- You have an email address.
- You can read and write in English or Spanish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a platform where you can track your experiences and concerns about cancer medications. It aims to help you and your care team manage medication safety.
This study tests whether text message reminders help women with early-stage, hormone-sensitive breast cancer remember to take their daily cancer-prevention medication. The goal is to see if reminders improve how consistently women take their pills, which can help prevent cancer from coming back.
This study tests a program to help people with metastatic breast cancer take their endocrine therapy, CDK4/6 inhibitors, and heart-related medications as prescribed. If you sometimes miss doses of these medicines, you may be able to join.
This trial tests a mobile health program to help women manage symptoms and stay healthy while taking hormone therapy (like tamoxifen or anastrozole) for early-stage breast cancer. It involves using a smartphone app and an electronic pill bottle to track your health and medication.
This study tests if a text message program can help Latina breast cancer patients remember to take their hormone therapy pills. It also looks at how non-medical challenges (like money or housing issues) affect medication taking.
This study tests a program to help people with metastatic breast cancer take their oral medications as prescribed. It uses a smartphone app to track and support medication adherence, which may improve treatment outcomes.
Hear when a new Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.